Stitch Fix CTO sells 70,000 shares, exercises options
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Stitch Fix, Inc. Chief Product/Technology Officer Anthony Bacos reported open-market sales totaling 70,000 shares of Class A common stock on July 13, 2026, in transactions at weighted-average prices of $3.6162 and $3.6164 per share, within a $3.57–$3.66 range, under a Rule 10b5-1 plan entered March 17, 2026.
On the same date, he exercised employee stock options for 50,000 shares at a $2.48 per-share exercise price, leaving 472,543 option shares outstanding on that award.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Bacos Anthony
Role
Chief Prod/Technology Officer
Sold
70,000 shs ($253K)
Approx. gross sale proceeds
$253K
Approx. exercise cost
$124K
Share of Position Sold
6.5%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) F1, F3 | 50,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock F1 | 50,000 | $2.48 | $124K |
| Sale | Class A Common Stock F1, F2 | 50,000 | $3.6164 | $181K |
| Sale | Class A Common Stock F1, F2 | 20,000 | $3.6162 | $72K |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 472,543 contracts (Direct);
Class A Common Stock — 1,011,994 shares (Direct)
Holdings Before and After:
Employee Stock Option (Right to Buy), 522,543 to 472,543 contracts (Direct);
Class A Common Stock, 1,031,994 to 1,011,994 shares (Direct)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (3)
- F1. This transaction was made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026.
- F2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.57 to $3.66 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. 25% of the shares subject to the Option vested on June 12, 2024. The remaining shares subject to the Option shall vest as follows: 25% of the shares in equal quarterly installments over the next two (2) quarterly vesting dates; 33 1/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates; and 16 2/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates, subject to the recipient's continuous service through each vesting date.
Key Figures
Shares sold (first transaction): 20,000 shares
Shares sold (second transaction): 50,000 shares
Total shares sold: 70,000 shares
+5 more
8 metrics
Shares sold (first transaction)
20,000 shares
Class A common stock sold on July 13, 2026 at $3.6162 per share
Shares sold (second transaction)
50,000 shares
Class A common stock sold on July 13, 2026 at $3.6164 per share
Total shares sold
70,000 shares
Aggregate net shares sold across reported transactions
Option shares exercised
50,000 shares
Employee stock options exercised for Class A common stock on July 13, 2026
Option exercise price
$2.48 per share
Conversion or exercise price of employee stock options exercised
Remaining option shares
472,543 shares
Employee stock options outstanding after the reported exercise
10b5-1 plan date
March 17, 2026
Date the Rule 10b5-1 trading plan governing these sales was entered
Option expiration
April 1, 2034
Expiration date of the reported employee stock option award
Key Terms
Rule 10b5-1 plan, weighted average sale price, Employee Stock Option, vesting, +1 more
5 terms
Rule 10b5-1 plan regulatory
"This transaction was made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average sale price financial
"The reported price in Column 4 is a weighted average sale price"
Employee Stock Option financial
"Security title listed as Employee Stock Option (Right to Buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
vesting financial
"25% of the shares subject to the Option vested on June 12, 2024"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
quarterly installments financial
"shares in equal quarterly installments over the next quarterly vesting dates"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider stock transactions did Stitch Fix (SFIX) report for Anthony Bacos?
Stitch Fix reported that Chief Product/Technology Officer Anthony Bacos sold 70,000 shares of Class A common stock and exercised options for 50,000 shares on July 13, 2026. These transactions combined open-market sales with an employee stock option exercise.
Were the recent Stitch Fix (SFIX) insider sales by Anthony Bacos under a Rule 10b5-1 plan?
Yes. The filing states the transactions were made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026. Such pre-arranged plans automate trading and can reduce the significance of trade timing as an indicator of insider sentiment.
What options did Stitch Fix (SFIX) executive Anthony Bacos exercise in the latest Form 4?
Anthony Bacos exercised 50,000 employee stock options for Stitch Fix Class A common stock on July 13, 2026. The options had a $2.48 per-share exercise price and relate to an award that now has 472,543 option shares remaining outstanding.
What is the vesting schedule for the Stitch Fix (SFIX) options exercised by Anthony Bacos?
The option award vested 25% on June 12, 2024. The remaining shares vest in quarterly installments, with 25% vesting over the next two quarterly dates, 33 1/3% over the next four, and 16 2/3% over the following four, subject to continuous service.
When do the Stitch Fix (SFIX) employee stock options held by Anthony Bacos expire?
The employee stock option reported in the filing has an expiration date of April 1, 2034. After exercising 50,000 shares on July 13, 2026, the award continues with 472,543 option shares outstanding, subject to its vesting terms and conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
